Other languages GSK plc

Equities

GSK

GB00BN7SWP63

Real-time Estimate Cboe Europe Other stock markets 06:03:02 2024-04-24 am EDT			5-day change	1st Jan Change
1,656 ^GBX	+0.27%		+3.82%	+13.83%

10:51am	GSK: FDA priority review for endometrial cancer	CF
10:14am	GSK's Jemperli with chemotherapy accepted for priority review by FDA	AN

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

GSK : étude prioritaire de la FDA pour le cancer d'endomètre	04:51am
GSK's Jemperli with chemotherapy accepted for priority review by FDA	04:14am
GSK Secures US FDA's Priority Review for Expanded Use of Endometrial Cancer Treatment	03:12am
GSK Says U.S. FDA Accepts New Indication Filing For Jemperli	02:16am
Edwards Lifesciences Corporation: het verhaal gaat verder	Apr. 23
Edwards Lifesciences Corporation : La historia continúa	Apr. 23
Edwards Lifesciences Corporation: Fortlaufende Erfolgsgeschichte	Apr. 23
Edwards Lifesciences Corporation: la storia continua	Apr. 23
Edwards Lifesciences Corporation : L’histoire se poursuit	Apr. 23
European Equities Close Higher in Monday Trading; EC Probes TikTok Over Possible DSA Violations	Apr. 22
Studie: Brexit-Folgen verschärfen britische Arzneimittelknappheit	Apr. 18
Met vallen en opstaan: waterstof	Apr. 17
GSK : résultats cliniques positifs dans la gonorrhée	Apr. 17
Gsk plc Announces New Long-Term Data Show Shingrix Continues to Provide High Protection Against Shingles in Adults Aged 50 and over for More Than A Decade	Apr. 17
GSK : le virus contre le zona efficace pendant plus de 10 ans	Apr. 17
GSK hails data on Shingles vaccine and gonorrhoea treatment	Apr. 17
GSK plc Announces Positive Results from the Pivotal Eagle-1 Phase III Trial for Gepotidacin	Apr. 17
China GDP Beat Fails to Boost Sentiment as UK's FTSE 100 Index Sheds Nearly 2%	Apr. 16
No habia que invitarlo: El hidrógeno	Apr. 16
GSK plc Announces US Food and Drug Administration Accepts for Review Biologics License Application for its 5-in-1 Meningococcal ABCWY Vaccine Candidate	Apr. 16

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

GSK PLC : 2023 ended on a strong note; medium- to long-term guidance raised

February 02, 2024 at 09:40 am EST